Poland
· Delayed Price · Currency is PLN MedApp Statistics
Total Valuation
MedApp has a market cap or net worth of PLN 45.02 million. The enterprise value is 50.81 million.
| Market Cap | 45.02M |
| Enterprise Value | 50.81M |
Important Dates
The next estimated earnings date is Monday, March 17, 2025.
| Earnings Date | Mar 17, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
MedApp has 250.13 million shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 250.13M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 120.53M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 8.44 |
| PB Ratio | 1.93 |
| P/TBV Ratio | 3.66 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.99, with an EV/FCF ratio of -7.35.
| EV / Earnings | -12.35 |
| EV / Sales | 9.53 |
| EV / EBITDA | 8.99 |
| EV / EBIT | n/a |
| EV / FCF | -7.35 |
Financial Position
The company has a current ratio of 2.73, with a Debt / Equity ratio of 0.12.
| Current Ratio | 2.73 |
| Quick Ratio | 0.24 |
| Debt / Equity | 0.12 |
| Debt / EBITDA | 0.57 |
| Debt / FCF | -0.47 |
| Interest Coverage | -19.69 |
Financial Efficiency
Return on equity (ROE) is -15.07% and return on invested capital (ROIC) is -3.79%.
| Return on Equity (ROE) | -15.07% |
| Return on Assets (ROA) | -3.11% |
| Return on Capital (ROIC) | -3.79% |
| Revenue Per Employee | 242,364 |
| Profits Per Employee | -186,955 |
| Employee Count | 37 |
| Asset Turnover | 0.15 |
| Inventory Turnover | 0.23 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -45.87% in the last 52 weeks. The beta is 0.92, so MedApp's price volatility has been similar to the market average.
| Beta (5Y) | 0.92 |
| 52-Week Price Change | -45.87% |
| 50-Day Moving Average | 0.17 |
| 200-Day Moving Average | 0.25 |
| Relative Strength Index (RSI) | 58.92 |
| Average Volume (20 Days) | 108,503 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, MedApp had revenue of PLN 5.33 million and -4.11 million in losses. Loss per share was -0.02.
| Revenue | 5.33M |
| Gross Profit | 4.28M |
| Operating Income | -1.73M |
| Pretax Income | -3.74M |
| Net Income | -4.11M |
| EBITDA | 5.65M |
| EBIT | -1.73M |
| Loss Per Share | -0.02 |
Balance Sheet
The company has 177,000 in cash and 3.22 million in debt, giving a net cash position of -3.05 million or -0.01 per share.
| Cash & Cash Equivalents | 177,000 |
| Total Debt | 3.22M |
| Net Cash | -3.05M |
| Net Cash Per Share | -0.01 |
| Equity (Book Value) | 26.09M |
| Book Value Per Share | 0.09 |
| Working Capital | 15.97M |
Cash Flow
In the last 12 months, operating cash flow was -6.88 million and capital expenditures -37,000, giving a free cash flow of -6.92 million.
| Operating Cash Flow | -6.88M |
| Capital Expenditures | -37,000 |
| Free Cash Flow | -6.92M |
| FCF Per Share | -0.03 |
Margins
Gross margin is 80.27%, with operating and profit margins of -32.50% and -77.14%.
| Gross Margin | 80.27% |
| Operating Margin | -32.50% |
| Pretax Margin | -70.22% |
| Profit Margin | -77.14% |
| EBITDA Margin | 105.98% |
| EBIT Margin | -32.50% |
| FCF Margin | n/a |
Dividends & Yields
MedApp does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -9.36% |
| FCF Yield | -15.37% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
MedApp has an Altman Z-Score of 5.96.
| Altman Z-Score | 5.96 |
| Piotroski F-Score | n/a |